Theriva Biologics SL
🇪🇸Spain
- Country
- 🇪🇸Spain
- Ownership
- Subsidiary
- Established
- 2009-01-01
- Employees
- 11
- Market Cap
- -
Clinical Trials
3
Active:0
Completed:3
Trial Phases
2 Phases
Phase 1:2
Phase 2:1
Drug Approvals
0
Drug Approvals
No drug approvals found
This company may not have drug approvals in our database
Clinical Trials
Distribution across different clinical trial phases (3 trials with phase data)• Click on a phase to view related trials
Phase 1
2 (66.7%)Phase 2
1 (33.3%)Study to evaluate the impact of VCN-01 on the overall survival of patients with advanced pancreatic cancer treated with standard therapy.
Phase 2
Completed
- Conditions
- Metastatic Pancreatic Cancer
- First Posted Date
- 2024-10-02
- Last Posted Date
- 2024-11-21
- Lead Sponsor
- Theriva Biologics S.L., Theriva Biologics S.L.
- Target Recruit Count
- 92
- Registration Number
- 2024-511290-30-00
- Locations
- 🇪🇸
Institut Catala D'oncologia, L'hospitalet De Llobregat, Spain
🇪🇸Vall D'hebron Institut De Recerca, Barcelona, Spain
🇪🇸Hospital General Universitario De Valencia, Valencia, Spain
A Phase I Dose Escalation Study of Intratumoral VCN-01 Injections With Gemcitabine and Abraxane® in Patients With Advanced Pancreatic Cancer
Phase 1
Completed
- Conditions
- Pancreatic AdenocarcinomaMetastatic Pancreatic Adenocarcinoma
- Interventions
- First Posted Date
- 2014-01-27
- Last Posted Date
- 2018-10-01
- Lead Sponsor
- Theriva Biologics SL
- Target Recruit Count
- 8
- Registration Number
- NCT02045589
- Locations
- 🇪🇸
Institut Català d'Oncologia, L'Hospitalet De Llobregat, Barcelona, Spain
🇪🇸Centro Integral Oncológico Clara Campal, Madrid, Spain
🇪🇸Hospital Universitario 12 de Octubre, Madrid, Spain
Phase I Dose Escalation Study of Intravenous VCN-01 With or Without Gemcitabine and Abraxane® in Patients With Advanced Solid Tumors
Phase 1
Completed
- Conditions
- Pancreatic AdenocarcinomaLocally Advanced Solid TumorsMetastatic Solid Tumors
- Interventions
- First Posted Date
- 2014-01-27
- Last Posted Date
- 2020-10-08
- Lead Sponsor
- Theriva Biologics SL
- Target Recruit Count
- 42
- Registration Number
- NCT02045602
- Locations
- 🇪🇸
Hospital Vall d'Hebron, Barcelona, Spain
🇪🇸Institut Català d'Oncologia, Hospitalet De Llobregat, Spain
🇪🇸Centro Integral Oncológico Clara Campal, Madrid, Spain
News
No news found